ArticleAnti-cancer drugs2026

Comparative efficacy and safety of S-1 plus oxaliplatin with sintilimab vs. paclitaxel-S-1-oxaliplatin and docetaxel-oxaliplatin-5-fluorouracil as first-line therapy for advanced gastric cancer.

Yicong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.